Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHSE: 688076)
Health Care · Pharmaceuticals · CN
CN¥27.93
+2.91% today · -34.7% 1Y
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHSE: 688076) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.31B and employs 2,360 people.
Over the last twelve months the share price has lost 34.7%, trading between 25.70 and 46.95.
Tweenvest scores Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. across four factors: quality 62/100, value 78/100, growth 86/100, dividend 23/100. Its strongest factor is growth.
688076 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.31B
- Revenue (TTM)
- $299.46M
- P/E
- 37.20
- EPS
- 0.98
- Dividend yield
- 1.29%
- Beta (5Y)
- 0.26
- 52-week high
- CN¥46.95
- 52-week low
- CN¥25.70
- Avg volume (3M)
- —
- Shares outstanding
- 316.05M
- Employees
- 2,360
- Next earnings
- —
About Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
- ISIN
- CNE1000051X5
- Founded
- 2009
- Listed since
- May 20, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF375.40 | +0.43% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.86 | -0.72% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.